Beyond THC and CBD: Minor Cannabinoids in Clinical Practice - Bonni Goldstein, MD [_cVAifvFYlN]

Beyond THC and CBD: Minor Cannabinoids in Clinical Practice - Bonni Goldstein, MD [_cVAifvFYlN]

| 1h 28m 28s | Video has closed captioning.

Tags: CBG, Cannabigerol, CBDA, THCA, CBDV, Glioblastoma, Neuroinflammation, Cannabis Research, Medicine Bonni Goldstein, MD, presents "Beyond THC and CBD: Minor Cannabinoids in Clinical Practice" at CannMed 23. 0:00 Intro 0:56 Phytocannabinoid Synthesis 1:40 CBG Targets 2:20 TRP Channels 3:37 CBG: Anti-Cancer 6:35 CBG: Reduces Neuroinflammation 7:18 CBG: Analgesic 7:36 CBG: Appetite Simulation 8:17 CBG: Metabolic Homeostasis 9:10 CBG: Anti-Psoriatic / Skin Effects 9:33 CBG: Anxiety / Depression 10:00 CBDA Targets 11:31 CBDA Anticonvulsant Effects 14:35 CBDA 15:45 CBDA: Patient Report 18:29 Targets of THCA 20:48 THCA: Patient Report 24:50 CBDV Targets 29:48 CBDV: Patient Report 32:44 Q&A Although research on phytocannabinoids has focused on THC and CBD, the so-called “minor” cannabinoids have become readily available and are being employed by patients to treat medical conditions, as well as being added to wellness regimens. What do we know about the minor cannabinoids and what conditions might benefit from them? Dr. Goldstein will review the mechanisms of action for CBG, CBDA, THCA and CBDV, the latest scientific findings, as well as her experience using these compounds in clinical practice. Learn More about CannMed: #cbd diet gummies #martha stewart cbd gummy #bliss rise cbd gummies #gummies cbd 1000mg